Consider New Nuplazid for Some Patients With Parkinson's Psychosis

The new antipsychotic, Nuplazid (new-PLAH-zid, pimavanserin), will raise questions about treating psychotic symptoms in Parkinson's patients.

Psychosis is common in Parkinson's...partly because the meds used to improve tremors and stiffness may cause hallucinations and delusions.

But antipsychotics block dopamine and can worsen motor function.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote